Michael I Robinson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael I Robinson

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of the American Dental Association (1939)|February 13, 2004

Manual dexterityMichael I Robinson

Molecular Therapy. Methods & Clinical Development|December 14, 2020

Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement VectorTierra A Bobo, Preston N Samowitz, Michael I Robinson, et al.

Gene Therapy|October 17, 2022

IgG-cleavage protein allows therapeutic AAV gene delivery in passively immunized MPS IIIA miceTierra A Bobo, Preston N Samowitz, Michael I Robinson, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of the American Dental Association (1939)|February 13, 2004

Manual dexterityMichael I Robinson

Molecular Therapy. Methods & Clinical Development|December 14, 2020

Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement VectorTierra A Bobo, Preston N Samowitz, Michael I Robinson, et al.

Gene Therapy|October 17, 2022

IgG-cleavage protein allows therapeutic AAV gene delivery in passively immunized MPS IIIA miceTierra A Bobo, Preston N Samowitz, Michael I Robinson, et al.

Pageof 1